Stem Cell Research & Therapy (Mar 2021)

Will mesenchymal stem cells be future directions for treating radiation-induced skin injury?

  • Zhuoqun Fang,
  • Penghong Chen,
  • Shijie Tang,
  • Aizhen Chen,
  • Chaoyu Zhang,
  • Guohao Peng,
  • Ming Li,
  • Xiaosong Chen

DOI
https://doi.org/10.1186/s13287-021-02261-5
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Radiation-induced skin injury (RISI) is one of the common serious side effects of radiotherapy (RT) for patients with malignant tumors. Mesenchymal stem cells (MSCs) are applied to RISI repair in some clinical cases series except some traditional options. Though direct replacement of damaged cells may be achieved through differentiation capacity of MSCs, more recent data indicate that various cytokines and chemokines secreted by MSCs are involved in synergetic therapy of RISI by anti-inflammatory, immunomodulation, antioxidant, revascularization, and anti-apoptotic activity. In this paper, we not only discussed different sources of MSCs on the treatment of RISI both in preclinical studies and clinical trials, but also summarized the applications and mechanisms of MSCs in other related regenerative fields.

Keywords